<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR12">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Boráň</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Menezes-Ferreira</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Reischl</surname>
    <given-names>I</given-names>
   </name>
   <name>
    <surname>Celis</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Ferry</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Gänsbacher</surname>
    <given-names>B</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Clinical development and commercialization of advanced therapy medicinal products in the european union: how are the product pipeline and regulatory framework evolving?</article-title>
  <source>Hum Gene Ther Clin Dev</source>
  <year>2017</year>
  <volume>28</volume>
  <fpage>126</fpage>
  <lpage>135</lpage>
  <pub-id pub-id-type="doi">10.1089/humc.2016.193</pub-id>
  <?supplied-pmid 28510497?>
  <pub-id pub-id-type="pmid">28510497</pub-id>
 </element-citation>
</ref>
